Post Profile

Science 37 Raises $31M to Expand Virtual Clinical Trail Model

Science 37, Inc., a LosAngeles-based mobile technology and clinical trial startup that focuses on the development of networked patient-centric models for clinical research has raised $31 million in Series B funding led by Redmile Group. The Series B round also includes participation from Series A lead investors Lux Capital and dRx Capital, as well as... Read More
read more


Related Posts

Ybrain Raises $3.5M To Fund Trials Of Its Wearable For Alzheimer’s Patients

Technology : TechCrunch: Enterprise

Ybrain, a Korean startup that makes wearables for Alzheimer’s patients, announced today that it has raised $3.5 million in Series A funding led by Stonebridge Capital, bringing its total raised so far to $4.2 million. Co-founder Seu...

Oblong Industries raises $65 million for ‘Minority Report’ style gesture technologies

Technology : Venture Beat

Oblong Industries has raised $65 million in funding to build its technologies that that will make collaborative work much easier. Oblong is combining spatial, immersive, and gesture technologies, brought to you by John Underkoffler,...

ePatientFinder Lands $8.2M for Clinical Trail Exchange Platform

Medical / Healthcare IT : Healthcare IT Consultant Blog

ePatientFinder, an Austin-based digital health startup that uses algorithms to match physicians with potentially life-changing clinical trials for their patients, based on their existing EHR data has raised $8.2 million Series B fun...

Heal Lands $26.9M for Mobile On-Demand Doctor House Calls

Medical / Healthcare IT : Healthcare IT Consultant Blog

On-demand doctor house call service provider Heal has raised $26.9 million in Series A funding led by the Tull Investment Group. The round also includes participation from Breyer Capital, Qualcomm executive chairman Paul Jaobs, and ...

Science 37 raises $31 million to bring clinical trials to the home

Technology : Venture Beat

Clinical trial technology company Science 37 has raised $31 million in a series B round led by Redmile Group, with participation from Lux Capital, dRx Capital, and Sanofi-Genzyme BioVentures. Founded out of Los Angeles in 2014, Scie...


Copyright © 2016 Regator, LLC